EXPERIMENTAL AND MOLECULAR MEDICINE
Scope & Guideline
Empowering researchers with open access to cutting-edge findings.
Introduction
Aims and Scopes
- Molecular Mechanisms of Disease:
Focuses on the molecular pathways involved in various diseases, including cancer, metabolic disorders, and neurodegenerative diseases, providing insights into potential therapeutic targets. - Experimental Models and Techniques:
Utilizes diverse experimental models, including organoid systems, animal models, and advanced imaging techniques, to investigate disease mechanisms and test therapeutic interventions. - Translational Research:
Emphasizes the translation of laboratory findings into clinical applications, bridging the gap between basic science and clinical practice, particularly in oncology and regenerative medicine. - Immunology and Inflammation:
Explores the roles of immune responses and inflammation in disease progression and therapy, with a focus on therapeutic strategies that modulate immune pathways. - Genomics and Epigenetics:
Investigates the impact of genomic and epigenetic alterations on disease development and progression, employing cutting-edge sequencing technologies to elucidate complex biological processes. - Microbiome and Disease Interactions:
Examines the interactions between the microbiome and host physiology, particularly how these interactions influence disease states and therapeutic outcomes. - Advanced Therapeutics and Drug Development:
Covers innovative approaches in drug discovery, including the development of novel therapeutic agents, biomarker identification, and personalized medicine strategies.
Trending and Emerging
- Organoid Technology and Applications:
The use of organoids as models for disease research is rapidly expanding, allowing for more accurate studies of human physiology and disease mechanisms, as well as drug testing. - Targeted Cancer Therapies:
There is a growing focus on developing targeted therapies that exploit specific molecular pathways in cancer, reflecting advances in precision medicine. - RNA Biology and Therapeutics:
Research on the roles of non-coding RNAs, including microRNAs and long non-coding RNAs, is trending, with implications for cancer therapy and gene regulation. - Immunotherapy and Immune Modulation:
The exploration of novel immunotherapeutic strategies, including the manipulation of immune pathways and the development of immune checkpoint inhibitors, is gaining momentum. - Metabolic Reprogramming in Disease:
Research into how metabolic changes affect disease progression, particularly in cancer and metabolic disorders, is emerging as a critical area of study. - Microbiome Research and Health:
The investigation of the microbiome's role in health and disease is increasingly prominent, with implications for therapeutic interventions and understanding disease mechanisms. - Epigenetics and Disease:
The study of epigenetic modifications and their impact on gene expression and disease development is on the rise, highlighting the complexity of genetic regulation.
Declining or Waning
- Traditional Pharmacology:
Research focused on classical pharmacological approaches is less prevalent, as more emphasis is placed on targeted therapies and personalized medicine. - Basic Biochemistry:
While foundational biochemistry remains important, there is a noticeable shift towards more complex systems biology and molecular mechanisms, leading to a decline in studies centered solely on basic biochemical processes. - In vitro Cell Culture Studies:
The reliance on conventional in vitro studies has decreased, with a growing preference for more sophisticated models, such as organoids and 3D cultures, which better mimic in vivo conditions. - Animal Models of Disease:
The use of traditional animal models is declining in favor of more innovative and relevant models that can better replicate human disease mechanisms and responses to treatments. - Single Biomarker Studies:
Research focusing on single biomarkers is becoming less common as the field shifts towards integrative approaches that consider multiple factors and interactions within biological systems.
Similar Journals
Journal of Biomedical Research
Uncovering Breakthroughs in Health and DiseaseJournal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.
MOLECULAR AND CELLULAR BIOLOGY
Championing High-Impact Research in Cellular DynamicsMOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.
Physiology and Pharmacology
Catalyzing discoveries in physiology and pharmacology.Physiology and Pharmacology is a distinguished open access journal that has been disseminating high-quality research in the fields of physiology and pharmacology since its inception in 1997. Published by the Iranian Society of Physiology & Pharmacology, this journal offers a platform for scholars and practitioners to share innovative findings and advancements that contribute to the understanding of biological systems and drug action. With its ISSN 2476-5236 and E-ISSN 2476-5244, it ensures global reach and accessibility. The journal is positioned in the third quartile for Linguistics and Language and fourth quartile in both Pharmacology and Physiology categories according to Scopus rankings, reflecting a commitment to expanding knowledge within these interdisciplinary domains. Set within the academic landscape of Iran, the journal aims to bridge regional research with the international community, providing valuable insights into physiological processes and pharmacological developments. In light of its open access model, the Physiology and Pharmacology journal plays a crucial role in enhancing the visibility of research outcomes and fostering collaboration among researchers, professionals, and students on a global scale.
CURRENT MOLECULAR MEDICINE
Unveiling Innovations in Biochemistry and GeneticsCURRENT MOLECULAR MEDICINE is a pivotal journal fostering advancements in the interdisciplinary fields of molecular medicine, biochemistry, and genetics. Published by Bentham Science Publishers, this esteemed journal has been disseminating vital research findings since its inception in 2001 and is continuously dedicated to exploring the molecular basis of health and disease. With a focus on translational research, CURRENT MOLECULAR MEDICINE provides an invaluable platform for researchers, healthcare professionals, and students, making significant contributions to the understanding of molecular mechanisms and therapeutic strategies. With an ISSN of 1566-5240 and an E-ISSN of 1875-5666, the journal holds a commendable position within the scientific community, being ranked Q3 in Biochemistry and Molecular Biology and Q2 in Medicine (miscellaneous) as of 2023. This journal does not currently operate on an open access model but remains accessible through various institutional subscriptions. The multidisciplinary scope covering molecular biology to medicinal applications positions CURRENT MOLECULAR MEDICINE as an essential resource for those striving to meet the challenges of modern healthcare and biomedical research.
Biomolecules and Biomedicine
Exploring the Molecular Basis of Life and DiseaseBiomolecules and Biomedicine is a pioneering open-access journal dedicated to advancing the fields of molecular biology and biomedical sciences, published by the Association of Basic Medical Science Federation Bosnia & Herzegovina in Sarajevo. With the ISSN 2831-0896 and the E-ISSN 2831-090X, this journal aims to facilitate the dissemination of high-quality research from 2023 onwards, inviting submissions that provide innovative insights and findings across various facets of medicine and biological sciences. Positioned within the General Medicine and Biochemistry, Genetics and Molecular Biology categories, it currently holds rankings of 332 out of 636 and 173 out of 221 respectively, highlighting its emerging influence in these fields. As an open-access journal, it ensures that all published research is freely accessible to a global audience, fostering collaboration and knowledge exchange among researchers, professionals, and students alike. With a commitment to enhancing scientific discourse and promoting cutting-edge research, Biomolecules and Biomedicine is poised to become a vital resource for those dedicated to unraveling the complexities of biomolecules and their roles in health and disease.
MOLECULES AND CELLS
Fostering Innovation in Biomedical ResearchMOLECULES AND CELLS is a distinguished peer-reviewed journal published by the Korean Society for Molecular and Cellular Biology, dedicated to advancing the fields of Cell Biology, Molecular Biology, and Medicine. With a solid citation record and a robust reputation in its respective categories, the journal has achieved a ranking of Q2 in Cell Biology and Q1 in Miscellaneous Medicine as of 2023, demonstrating its impact and relevance to ongoing research in these vital disciplines. Although currently not open access, MOLECULES AND CELLS strives to provide a platform for innovative studies from diverse areas within molecular and cellular research, fostering collaboration among scientists worldwide. Established in 1996 and continuing to publish leading-edge research until 2024, this journal is essential for researchers, professionals, and students seeking to engage with the latest developments and insights in the life sciences.
Frontiers in Bioscience-Landmark
Uncovering Landmark Research in Life SciencesFrontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Connecting Scientists to Transform Pathological UnderstandingINTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.
MOLECULAR ASPECTS OF MEDICINE
Illuminating the Pathways of Molecular ResearchMOLECULAR ASPECTS OF MEDICINE is a premier journal published by Elsevier, focusing on groundbreaking research in the fields of biochemistry, molecular biology, and medicine. With an impressive impact factor and ranking within the top quartile across multiple categories, including Q1 in Biochemistry, Clinical Biochemistry, and Molecular Medicine, it serves as an essential platform for sharing innovative findings that advance our understanding of molecular mechanisms in health and disease. The journal, which has been in publication since 1976, provides a diverse range of articles, addressing both fundamental and applied aspects of molecular medicine, thus appealing to a broad audience of researchers, professionals, and students. While MOLECULAR ASPECTS OF MEDICINE does not currently offer Open Access options, it remains a vital resource for accessing high-quality, peer-reviewed scholarly works that significantly contribute to the advancement of biomedical research.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Transforming Understanding through Molecular BiologyBIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.